<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04625920</url>
  </required_header>
  <id_info>
    <org_study_id>0793-19</org_study_id>
    <nct_id>NCT04625920</nct_id>
  </id_info>
  <brief_title>A Virtual Reality System for Pain and Anxiety Management During Outpatient Hysteroscopy</brief_title>
  <official_title>A Virtual Reality System for Pain and Anxiety Management During Outpatient Hysteroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effectiveness of VR as a distraction technique in the management of acute&#xD;
      pain and anxiety during operative hysteroscopy in the outpatient setting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, open-label, randomized control trial in a tertiary university-affiliated&#xD;
      medical center between April to August 2020. Overall, 100 women will be randomly allocated to&#xD;
      undergo operative hysteroscopy either with the use of VR (study group) or with standard&#xD;
      treatment (control group). The primary outcome measures includ self-reported pain, anxiety&#xD;
      scores, and vital parameters as pulse rate (PR) and respiratory rate (RR). Pain and anxiety&#xD;
      outcomes were measured as numeric rating scores.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 10, 2020</start_date>
  <completion_date type="Actual">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">September 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessments of pain through physiological parameters</measure>
    <time_frame>10 minutes</time_frame>
    <description>Assessments of pain through physiological parameters of pulse rate. Heart Rate will be measured using Heart Rate-beats per minute.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessments of pain through pain score parameter</measure>
    <time_frame>10 minutes</time_frame>
    <description>Assessments of pain through pain score parameter of the NRS questionnaire. Pain will be measured using the Numeric Rating Scale (NRS) which is a 11 point scale from 0 to 10 which is a validated score of measuring pain and anxiety in which 0 is no pain and 10 is the worst imaginable pain and or anxiety.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Infertility</condition>
  <condition>Vaginal Blood Loss</condition>
  <arm_group>
    <arm_group_label>Virtual reality</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>women allocated to undergo hysteroscopy with Vr System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standart care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>women allocated to undergo hysteroscopy without VR</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SootheVR: AppliedVR, Los Angeles, California</intervention_name>
    <description>a head-mounted display</description>
    <arm_group_label>Standart care</arm_group_label>
    <arm_group_label>Virtual reality</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  . Women with suspected infection&#xD;
&#xD;
          -  women considered not suitable to undergo an office hysteroscopy&#xD;
&#xD;
          -  women who reported the use of analgesia 6 hours prior to the procedure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient needed office hysteroscopy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>eli shprecher, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>souraski MC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lis Maternity Hospital, Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Souraski MC</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 27, 2020</study_first_submitted>
  <study_first_submitted_qc>November 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2020</study_first_posted>
  <last_update_submitted>November 8, 2020</last_update_submitted>
  <last_update_submitted_qc>November 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel-Aviv Sourasky Medical Center</investigator_affiliation>
    <investigator_full_name>michal roll</investigator_full_name>
    <investigator_title>Director, Head of Clinical Trails Department, Principal Investigator, Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Hysteroscopy</keyword>
  <keyword>VR</keyword>
  <keyword>Vurtual reality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

